Status:
COMPLETED
Prognostic Value of Lung Ultrasound in ST Segment Elevation Acute Myocardial Infarction (LUS-AMI)
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborating Sponsors:
Institut Hospital del Mar d'Investigacions Médiques
Hospital Vall d'Hebron
Conditions:
Acute Myocardial Infarction
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to asses the prognostic value of lung ultrasound in patients with ST-segment elevation acute myocardial infarction.
Detailed Description
LUS-AMI is an observational cohort prospective study that evaluates the prognostic value of lung ultrasound, specifically the number of B-lines, performed within the first 24 hours after and ST-segmen...
Eligibility Criteria
Inclusion
- Adults (more than 18 years) admitted with confirmed ST-segment elevation acute myocardial infarction (STEMI).
Exclusion
- Absence of coronary artery disease and myocardial injury (false positive)
- Non interpretable lung ultrasound
- Severe lung disease (fibrosis, severe COPD, pleural disease, lobectomy or pneumonectomy)
- Acute respiratory distress syndrome
- Pneumonia or SDRA at admission or during hospitalization
- Follow-up inability
- Hemodialysis therapy previous to admission
- Life expectancy less than 6 months secondary to extracardiac pathology.
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04526535
Start Date
June 15 2020
End Date
December 31 2022
Last Update
March 1 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
2
Hospital del Mar
Barcelona, Spain